Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
-
* Corresponding author: Mervi Jumppanen mervi.jumppanen@epshp.fi
- Equal contributors
Breast Cancer Research 2007, 9:R16 doi:10.1186/bcr1649
Accesses
- Last 30 days: 174 accesses
- Last year: 1860 accesses
- All time: 14276 accesses
Cited by
BioMed Central: 7 citations
|
Eleonor Olsson, Gabriella Honeth, Pär-Ola Bendahl, Lao H Saal, Sofia Gruvberger-Saal, Markus Ringnér, Johan Vallon-Christersson, Göran Jönsson, Karolina Holm, Kristina Lövgren, Mårten Fernö, Dorthe Grabau, Åke Borg, Cecilia Hegardt BMC Cancer 2011, 11:418 (29 September 2011) |
|
Does vimentin help to delineate the so-called 'basal type breast cancer'? Renata U Kusinska, Radzislaw Kordek, Elzbieta Pluciennik, Andrzej K Bednarek, Janusz H Piekarski, Piotr Potemski Journal of Experimental & Clinical Cancer Research 2009, 28:118 (20 August 2009) |
|
Andrew E Teschendorff, Carlos Caldas Breast Cancer Research 2008, 10:R73 (28 August 2008) |
|
The CD44+/CD24- phenotype is enriched in basal-like breast tumors Gabriella Honeth, Pär-Ola Bendahl, Markus Ringnér, Lao H Saal, Sofia K Gruvberger-Saal, Kristina Lövgren, Dorthe Grabau, Mårten Fernö, Åke Borg, Cecilia Hegardt Breast Cancer Research 2008, 10:R53 (17 June 2008) Basal-like and particularly BRCA1 hereditary breast cancer are associated with CD44+/CD24- cells, however tumorigenicity may not be confined to cells of this phenotype as they are found in very few HER2+ tumours.
|
|
Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families Hannaleena Eerola, Mira Heinonen, Päivi Heikkilä, Outi Kilpivaara, Anitta Tamminen, Kristiina Aittomäki, Carl Blomqvist, Ari Ristimäki, Heli Nevanlinna Breast Cancer Research 2008, 10:R17 (14 February 2008) |
|
Are triple-negative tumours and basal-like breast cancer synonymous? Emad A Rakha, David SP Tan, William D Foulkes, Ian O Ellis, Andrew Tutt, Torsten O Nielsen, Jorge S Reis-Filho Breast Cancer Research 2007, 9:404 (30 November 2007) |
|
Andrew E Teschendorff, Ahmad Miremadi, Sarah E Pinder, Ian O Ellis, Carlos Caldas Genome Biology 2007, 8:R157 (2 August 2007) A feature selection method was used in an analysis of three major microarray expression datasets to identify molecular subclasses and prognostic markers in estrogen receptor-negative breast cancer, showing that it is a heterogeneous disease with at least four main subtypes. |